文献速递神经MR

基于影像组学的MRI预测弥漫性胶质瘤EphA2表达及肿瘤分级

Radiomics-based MRI for predicting Erythropoietin-producing hepatocellular receptor A2 expression and tumor grade in brain diffuse gliomas.
PubMed 文献 · Neuroradiology · 2021-08-09

本研究纳入182例弥漫性胶质瘤患者,提取三维增强T1加权成像和扩散峰度成像的影像组学特征,构建机器学习模型预测EphA2表达和肿瘤分级。逻辑回归模型预测EphA2表达的AUC在训练集和验证集分别为0.836和0.724;基于EphA2模型特征构建的分级模型AUC为0.930和0.983,与直接使用影像组学特征的分级模型(AUC 0.960/0.977)性能相当。结论提示扩散峰度MRI影像组学特征可预测EphA2表达并辅助肿瘤分级。

要点

  • 扩散峰度MRI影像组学特征可用于无创预测弥漫性胶质瘤EphA2表达状态。
  • 基于EphA2相关特征构建的模型对肿瘤分级具有高判别性能(验证集AUC 0.983)。
  • EphA2表达预测模型以逻辑回归分类器性能最佳。

核心结论

  • 弥漫性胶质瘤的EphA2表达可通过扩散峰度MRI影像组学特征预测,并可用于辅助肿瘤分级。

研究设计与样本

  • 回顾性研究纳入182例弥漫性胶质瘤患者,均行术前MRI和术后病理诊断。
  • EphA2表达采用免疫组化染色(单克隆EphA2抗体)评分。
  • 影像组学特征提取自三维对比增强T1加权成像和扩散峰度成像。
  • 采用机器学习特征选择和三种分类器构建预测模型,146例(80%)为训练集,36例(20%)为测试集。

诊断标准与关键数值

  • 逻辑回归模型预测EphA2表达的AUC在训练集为0.836,验证集为0.724。
  • 基于EphA2表达模型特征构建的肿瘤分级模型AUC在训练集为0.930,验证集为0.983。
  • 直接使用影像组学特征构建的分级模型AUC在训练集为0.960,验证集为0.977。
  • 两个LR分级模型中包含的两个影像组学特征与EphA2表达呈强相关(P < 0.05)。

临床应用与阅片要点

  • 术前MRI影像组学分析可在无创条件下提示EphA2表达状态,辅助评估胶质瘤侵袭潜能。
  • 基于EphA2相关特征的影像组学模型可辅助胶质瘤分级,减少对有创病理的依赖。

局限性

  • 样本量有限(182例),验证集仅36例,可能影响模型稳定性。
  • 单中心回顾性设计,需外部多中心验证。
  • EphA2表达预测模型验证集AUC(0.724)低于训练集,存在一定过拟合风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: EphA2 is a key factor underlying invasive propensity of gliomas, and is associated with poor prognosis of tumors. We aimed to develop a radiomics-based imaging index for predicting EphA2 expression in diffuse gliomas, and further estimating its value for grading of tumors.

METHODS: A total of 182 patients with diffuse gliomas were included. All subjects underwent pre-operative MRI and post-operative pathological diagnosis. EphA2 expression of tumors was scored on pathological sections with immunohistochemical staining using monoclonal EphA2 antibody. MRI radiomics features were extracted from three-dimensional contrast-enhanced T1-weighted imaging and diffusion kurtosis imaging. Predictive models were constructed using machine learning-based radiomics features selection and three classifiers for predicting EphA2 expression and tumor grade. Features of best EphA2 expression model were subsequently used to construct another model of tumor grading. For each model, 146 cases (80%) were randomly picked as training and the rest 36 (20%) were testing cohorts. EphA2 expression was further correlated to the radiomics features in both grade models using Spearman's correlation.

RESULTS: Logistic regression model presented highest performance for predicting EphA2 expression (AUC: 0.836/0.724 in training/validation set). Tumor gradings model guided by features from EphA2 expression model demonstrated comparable performance (AUC: 0.930/0.983) to that constructed directly using imaging radiomics features (AUC: 0.960/0.977). Two radiomics features which included in both LR-grade models showed strong correlation (P < 0.05) with EphA2 expression.

CONCLUSION: The expression of EphA2 in gliomas could be predicted by radiomics features extracted from diffusion kurtosis MRI, which could also be used to assist tumor grading.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Liu X, Li J, Liao X, et al. Radiomics-based MRI for predicting Erythropoietin-producing hepatocellular receptor A2 expression and tumor grade in brain diffuse gliomas. Neuroradiology. 2021. PMID: 34368897. doi:10.1007/s00234-021-02780-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。